Increase in Hepatitis A Vaccination Needed to Prevent Deaths
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 25, 2023 -- Nearly two-thirds of those with hepatitis A virus (HAV)-related deaths have at least one documented indication for HAV vaccine, and only 4 percent have evidence of vaccination, according to research published in the Oct. 20 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Megan G. Hofmeister, M.D., from the CDC in Atlanta, and colleagues analyzed data from 27 HAV outbreak-affected states that contributed data during Aug. 1, 2016, to Oct. 31, 2022, to characterize demographic, risk factor, clinical, and cause-of-death data among 315 outbreak-related HAV deaths.
The researchers found that on 60 percent of available death certificates, HAV was documented as an underlying or contributing cause of death. There was a peak in outbreak-related deaths in 2019, which then decreased annually through 2022. The median age at death was 55 years; 73 and 84 percent of deaths occurred among males and non-Hispanic Whites, respectively. Overall, 63 percent of decedents had at least one documented indication for HAV vaccination, including drug use, homelessness, or coinfection with hepatitis B or hepatitis C (41, 16, 12, and 31 percent, respectively); evidence of previous HAV vaccination was seen for 4 percent.
"As of October 2023, 34 states have declared ends to their outbreaks; however, many susceptible adults, particularly among persons who use drugs, persons experiencing homelessness, and persons with chronic liver disease, remain at increased risk for HAV infection or severe disease from HAV infection," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Higher COVID-19 Vaccination Rates Tied to Decrease in Childhood Asthma Symptoms
WEDNESDAY, July 3, 2024 -- Higher COVID-19 vaccination rates are associated with a lower prevalence of parent-reported childhood asthma symptoms, according to a research letter...
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.